Ознакомительная версия. Доступно 9 страниц из 47
Регулярные выпуски ‘РМЖ’ 1421–1428 (2017).
102. Chasman, D. I. et al. Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA 291, 2821–7 (2004).
103. Liao, J. K. Safety and efficacy of statins in Asians. Am. J. Cardiol. 99, 410–4 (2007).
104. Stroes, E. S. et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur. Heart J. 36, 1012–22 (2015).
105. Kashani, A. et al. Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation 114, 2788–97 (2006).
106. Riaz, H. et al. Meta-analysis of Placebo-Controlled Randomized Controlled Trials on the Prevalence of Statin Intolerance. Am. J. Cardiol. 120, 774–781 (2017).
107. McGuinness, B., Craig, D., Bullock, R. & Passmore, P. Statins for the prevention of dementia. Cochrane Database Syst. Rev. (2016). doi:10.1002/14651858.CD003160.pub3
108. O’Donoghue, M. et al. Lipoprotein-Associated Phospholipase A 2 and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy – Thrombolysis In Myocardial Infarction) Trial. Circulation 113, 1745–1752 (2006).
109. Taylor, F. et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. (2013). doi:10.1002/14651858.CD004816.pub5
110. Silva, M. A., Swanson, A. C., Gandhi, P. J. & Tataronis, G. R. Statin-related adverse events: A meta-analysis. Clin. Ther. 28, 26–35 (2006).
111. Finegold, J. A., Manisty, C. H., Goldacre, B., Barron, A. J. & Francis, D. P. What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice. Eur. J. Prev. Cardiol. 21, 464–474 (2014).
112. Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 25, 486–541 (2018).
Ознакомительная версия. Доступно 9 страниц из 47
